A tactical nanomissile mobilizing antitumor immunity enables neoadjuvant chemo-immunotherapy to minimize postsurgical tumor metastasis and recurrence

• Main Authors: Tao He (Author), Mingxing Hu (Author), Shunyao Zhu (Author), Meiling Shen (Author), Xiaorong Kou (Author), Xiuqi Liang (Author), Lu Li (Author), Xinchao Li (Author), Miaomiao Zhang (Author), Qinjie Wu (Author), Changyang Gong (Author)
• Format: Book
• Published: Elsevier, 2023-02-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Neoadjuvant chemotherapy has become an indispensable weapon against high-risk resectable cancers, which benefits from tumor downstaging. However, the utility of chemotherapeutics alone as a neoadjuvant agent is incapable of generating durable therapeutic benefits to prevent postsurgical tumor metast...